ID   PLA2R_BOVIN             Reviewed;        1463 AA.
AC   P49259;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   03-AUG-2022, entry version 157.
DE   RecName: Full=Secretory phospholipase A2 receptor;
DE            Short=PLA2-R;
DE            Short=PLA2R;
DE   AltName: Full=180 kDa secretory phospholipase A2 receptor;
DE   AltName: Full=M-type receptor;
DE   Contains:
DE     RecName: Full=Soluble secretory phospholipase A2 receptor;
DE              Short=Soluble PLA2-R;
DE              Short=Soluble PLA2R;
DE   Flags: Precursor;
GN   Name=PLA2R1;
OS   Bos taurus (Bovine).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae;
OC   Bovinae; Bos.
OX   NCBI_TaxID=9913;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF N-TERMINUS.
RX   PubMed=7509792; DOI=10.1016/s0021-9258(17)37546-4;
RA   Ishizaki J., Hanasaki K., Higashino K., Kishino J., Kikuchi N., Ohara O.,
RA   Arita H.;
RT   "Molecular cloning of pancreatic group I phospholipase A2 receptor.";
RL   J. Biol. Chem. 269:5897-5904(1994).
RN   [2]
RP   FUNCTION.
RX   PubMed=7726849; DOI=10.1006/bbrc.1995.1502;
RA   Fujita H., Kawamoto K., Hanasaki K., Arita H.;
RT   "Glycosylation-dependent binding of pancreatic type I phospholipase A2 to
RT   its specific receptor.";
RL   Biochem. Biophys. Res. Commun. 209:293-299(1995).
CC   -!- FUNCTION: Receptor for secretory phospholipase A2 (sPLA2). Also able to
CC       bind to snake PA2-like toxins. Although its precise function remains
CC       unclear, binding of sPLA2 to its receptor participates in both positive
CC       and negative regulation of sPLA2 functions as well as clearance of
CC       sPLA2. Binding of sPLA2-IB/PLA2G1B induces various effects depending on
CC       the cell type, such as activation of the mitogen-activated protein
CC       kinase (MAPK) cascade to induce cell proliferation, the production of
CC       lipid mediators, selective release of arachidonic acid in bone marrow-
CC       derived mast cells. In neutrophils, binding of sPLA2-IB/PLA2G1B can
CC       activate p38 MAPK to stimulate elastase release and cell adhesion. May
CC       be involved in responses in pro-inflammatory cytokine productions
CC       during endotoxic shock. Also has endocytic properties and rapidly
CC       internalizes sPLA2 ligands, which is particularly important for the
CC       clearance of extracellular sPLA2s to protect their potent enzymatic
CC       activities. The soluble secretory phospholipase A2 receptor form is
CC       circulating and acts as a negative regulator of sPLA2 functions by
CC       blocking the biological functions of sPLA2-IB/PLA2G1B and sPLA2-
CC       X/PLA2G10. {ECO:0000269|PubMed:7726849}.
CC   -!- SUBUNIT: Interacts with sPLA2-IB/PLA2G1B; this interaction mediates
CC       intracellular signaling as well as clearance of extracellular sPLA2-
CC       IB/PLA2G1B via endocytotic pathway (By similarity). Interacts with
CC       sPLA2-X/PLA2G10; this interaction mediates sPLA2-X/PLA2G10 clearance
CC       and inactivation (By similarity). {ECO:0000250|UniProtKB:Q13018,
CC       ECO:0000250|UniProtKB:Q62028}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Soluble secretory phospholipase A2 receptor]:
CC       Secreted {ECO:0000250}.
CC   -!- DOMAIN: C-type lectin domains 3-5 mediate the interaction with
CC       phospholipase PLA2G1B. {ECO:0000250}.
CC   -!- DOMAIN: The endocytosis signal probably mediates endocytosis via
CC       clathrin-coated pits. {ECO:0000250}.
CC   -!- PTM: The secretory phospholipase A2 receptor form may be produced by
CC       the action of metalloproteinases. It contains all extracellular domains
CC       and only lacks transmembrane and cytosolic regions. It is however
CC       unclear whether this form is produced by proteolytic cleavage as
CC       suggested by some experiments, or by alternative splicing (By
CC       similarity). {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D16109; BAA03683.1; -; mRNA.
DR   PIR; A53210; A53210.
DR   RefSeq; NP_778221.1; NM_175051.1.
DR   AlphaFoldDB; P49259; -.
DR   SMR; P49259; -.
DR   STRING; 9913.ENSBTAP00000043437; -.
DR   PaxDb; P49259; -.
DR   Ensembl; ENSBTAT00000046112; ENSBTAP00000043437; ENSBTAG00000032515.
DR   GeneID; 317777; -.
DR   KEGG; bta:317777; -.
DR   CTD; 22925; -.
DR   VEuPathDB; HostDB:ENSBTAG00000032515; -.
DR   VGNC; VGNC:32966; PLA2R1.
DR   eggNOG; KOG4297; Eukaryota.
DR   GeneTree; ENSGT01050000244842; -.
DR   HOGENOM; CLU_002069_2_0_1; -.
DR   InParanoid; P49259; -.
DR   OrthoDB; 29241at2759; -.
DR   TreeFam; TF316663; -.
DR   Proteomes; UP000009136; Chromosome 2.
DR   Bgee; ENSBTAG00000032515; Expressed in omental fat pad and 97 other tissues.
DR   ExpressionAtlas; P49259; baseline and differential.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0043274; F:phospholipase binding; ISS:UniProtKB.
DR   GO; GO:0038023; F:signaling receptor activity; ISS:UniProtKB.
DR   GO; GO:0090403; P:oxidative stress-induced premature senescence; ISS:UniProtKB.
DR   GO; GO:0090238; P:positive regulation of arachidonic acid secretion; ISS:UniProtKB.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0043517; P:positive regulation of DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; ISS:UniProtKB.
DR   GO; GO:0090399; P:replicative senescence; ISS:UniProtKB.
DR   CDD; cd00062; FN2; 1.
DR   CDD; cd00161; RICIN; 1.
DR   Gene3D; 2.10.10.10; -; 1.
DR   Gene3D; 3.10.100.10; -; 8.
DR   InterPro; IPR001304; C-type_lectin-like.
DR   InterPro; IPR016186; C-type_lectin-like/link_sf.
DR   InterPro; IPR018378; C-type_lectin_CS.
DR   InterPro; IPR016187; CTDL_fold.
DR   InterPro; IPR000562; FN_type2_dom.
DR   InterPro; IPR036943; FN_type2_sf.
DR   InterPro; IPR035992; Ricin_B-like_lectins.
DR   InterPro; IPR000772; Ricin_B_lectin.
DR   Pfam; PF00040; fn2; 1.
DR   Pfam; PF00059; Lectin_C; 8.
DR   SMART; SM00034; CLECT; 8.
DR   SMART; SM00059; FN2; 1.
DR   SMART; SM00458; RICIN; 1.
DR   SUPFAM; SSF50370; SSF50370; 1.
DR   SUPFAM; SSF56436; SSF56436; 8.
DR   PROSITE; PS00615; C_TYPE_LECTIN_1; 3.
DR   PROSITE; PS50041; C_TYPE_LECTIN_2; 8.
DR   PROSITE; PS00023; FN2_1; 1.
DR   PROSITE; PS51092; FN2_2; 1.
DR   PROSITE; PS50231; RICIN_B_LECTIN; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Direct protein sequencing; Disulfide bond; Endocytosis;
KW   Glycoprotein; Lectin; Membrane; Receptor; Reference proteome; Repeat;
KW   Secreted; Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000269|PubMed:7509792"
FT   CHAIN           21..1463
FT                   /note="Secretory phospholipase A2 receptor"
FT                   /id="PRO_0000017550"
FT   CHAIN           21..?
FT                   /note="Soluble secretory phospholipase A2 receptor"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000311249"
FT   TOPO_DOM        21..1392
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1393..1421
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1422..1463
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          38..115
FT                   /note="Ricin B-type lectin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00174"
FT   DOMAIN          173..221
FT                   /note="Fibronectin type-II"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00479"
FT   DOMAIN          229..353
FT                   /note="C-type lectin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          357..500
FT                   /note="C-type lectin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          504..641
FT                   /note="C-type lectin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          646..795
FT                   /note="C-type lectin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          799..937
FT                   /note="C-type lectin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          941..1095
FT                   /note="C-type lectin 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1099..1230
FT                   /note="C-type lectin 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   DOMAIN          1235..1376
FT                   /note="C-type lectin 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00040"
FT   MOTIF           1436..1442
FT                   /note="Endocytosis signal"
FT   CARBOHYD        93
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        454
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1057
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        178..204
FT                   /evidence="ECO:0000250"
FT   DISULFID        192..219
FT                   /evidence="ECO:0000250"
FT   DISULFID        260..354
FT                   /evidence="ECO:0000250"
FT   DISULFID        330..346
FT                   /evidence="ECO:0000250"
FT   DISULFID        406..501
FT                   /evidence="ECO:0000250"
FT   DISULFID        478..493
FT                   /evidence="ECO:0000250"
FT   DISULFID        617..634
FT                   /evidence="ECO:0000250"
FT   DISULFID        699..796
FT                   /evidence="ECO:0000250"
FT   DISULFID        774..788
FT                   /evidence="ECO:0000250"
FT   DISULFID        840..938
FT                   /evidence="ECO:0000250"
FT   DISULFID        915..930
FT                   /evidence="ECO:0000250"
FT   DISULFID        992..1096
FT                   /evidence="ECO:0000250"
FT   DISULFID        1068..1088
FT                   /evidence="ECO:0000250"
FT   DISULFID        1209..1223
FT                   /evidence="ECO:0000250"
FT   DISULFID        1280..1377
FT                   /evidence="ECO:0000250"
FT   DISULFID        1354..1369
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1463 AA;  168651 MW;  4276FF206F92A397 CRC64;
     MPLLSLSLLL LLLQVPAGSA ETAAWAVTPE RLREWQDKGI FIIQSENLEK CIQASKSTLT
     LENCKPPNKY MLWKWVSNHR LFNIGGSGCL GLNVSSPEQP LSIYECDSTH VSLKWHCNKK
     TITGPLQYLV QVKQDNTLVA SRKYLHKWVS YMSGGGGICD YLHKDLYTIK GNAHGTPCMF
     PFQYNQQWHH ECTREGREDN LLWCATTSRY ERDEKWGFCP DPTSTEVGCD AVWEKDLHSR
     ICYQFNLLSS LSWSEAHSSC QMQGAALLSI ADETEENFVR KHLGSEAVEV WMGLNQLDED
     AGWQWSDRTP LNYLNWKPEI NFEPFVEYHC GTFNAFMPKA WKSRDCESTL PYVCKKYLNP
     TDHGVVEKDA WKYYATHCEP GWNPHNRNCY KLQKEKKTWN EALQSCQSNN SVLTDITSLA
     EVEFLVTLLG DENASETWIG LSSHKIPVSF EWSNGSSVTF TNWHTLEPHI FPNRSQLCVS
     AEQSEGHWKV KNCEETLFYL CKKTGLVLSD TESGCQKGWE RHGKFCYKID TVLRSFDHAS
     SGYYCPPALI TITSRFEQAF ITSLISSVVK TKDTYFWIAL QDQNNTGEYT WKTAGQQLEP
     VKYTHWNTRQ PRYSGGCVVM RGRSHPGRWE VRDCRHFKAM SLCKQPVENR EKTKQEEGWP
     FHPCYLDWES EPGLASCFKV FHSEKVLMKR TWRQAEEFCE EFGAHLASFA HIEEENFVNE
     LLHSKFNRTE ERQFWIGFNK RNPLNAGSWE WSDGTPVVSS FLDNSYFGED ARNCAVYKAN
     KTLLPSYCGS KREWICKIPR DVRPKVPPWY QYDAPWLFYQ DAEYLFHISA SEWSSFEFVC
     GWLRSDILTI HSAHEQEFIH SKIRALSKYG VNWWIGLREE RASDEFRWRD GSPVIYQNWD
     KGKERSMGLN ESQRCGFISS ITGLWASEEC SISMPSICKR KKVWVIEKKK DIPKQHGTCP
     KGWLYFDYKC LLLKIPEGPS DWKNWTSAQD FCVEEGGTLV AIENEVEQAF ITMNLFGHTT
     NVWIGLQDDD YEKWLNGRPV SYSNWSPFDT KNIPNHNTTE VQKRIPLCGL LSNNPNFHFT
     GKWYFEDCRE GYGFVCEKMQ DASGHSINTS DMYPIPNTLE YGNRTYKIIN ANMTWYTALK
     TCLMHGAELA SITDQYHQSF LTVILNRVGY AHWIGLFTED NGLSFDWSDG TKSSFTFWKD
     DESSFLGDCV FADTSGRWSS TACESYLQGA ICQVPTETRL SGRLELCSET SIPWIKFKSN
     CYSFSTVLES TSFEAAHEFC KKKGSNLLTI KDEAENSFLL EELLAFRSSV QMIWLNAQFD
     GDNETIKWFD GTPTDQSNWG IRKPEVYHFK PHLCVALRIP EGVWQLSSCQ DKKGFICKME
     ADIHTVKKHP GKGPSHSVIP LTVALTLLVI LAISTLSFCM YKHSHIIFGR LAQFRNPYYP
     SANFSTVHLE ENILISDLEK NDQ
//
